Cephalon | Home
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan ... Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed ...
http://www.cephalon.com/...
|
BioPortfolio - cephalon.com
BioPortfolio - www.cephalon.de www.cephalon.de - BioPortfolio. ... BioPortfolio - Cephalon GmbH - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/_cephalon.com.html...
|
Cephalon | Cephalon Receives FDA Approval for TREANDA to Treat ...
3 Nov 2008 ... Cephalon holds exclusive rights to market and develop TREANDA in the United States. TREANDA is licensed from Astellas Deutschland GmbH. ...
http://www.cephalon.com/media/news-releases/article/cephalon...
|
Cephalon Reacquires Rights to Modafinil in Major European Markets
Cephalon markets modafinil in the United States under the brand name ... and Eastern Europe from Merckle GmbH, and in Spain from Cepa Schwarz Pharma. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioWorld Today
24 Sep 2007 ... Treanda (bendamustine) is "well known outside the U.S." in its generic form, noted Jenifer Antonacci, Cephalon's senior manager of public ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
Nitec Pharma expands senior management team
Dr. Rainer Rogasch will work as Vice President Technical Operations & Development and was previously General Manager and Technical Director at Madaus
GmbH. ...
http://www.bioportfolio.com/biotech_news/Nitec_Pharma_5.htm...
|
Quarterly announcement at 31 March 2001
Company’s holding of Cephalon shares, the Company’s finance items ... purchase of Byk Gulden Lomberg Chemische Fabrik GmbH’s share of. Lundbeck GmbH & Co. ...
http://www.lundbeck.com/investor/Financials/Reports/Files/UK...
|
BioPortfolio - GenoVision Inc - Profile
Zacks Industry Rank Analysis Highlights: Cephalon, CONSOL Energy, Intel, Sunoco and Varian ... Peter Barfoot Managing Director, BioPortfolio Ltd. ...
http://www.bioportfolio.com/biocorporate/23472-GenoVision%25...
|
January 7, 2008
Appointed: Frank Mathias as executive director, formerly general manager. at Amgen Inc.’s Amgen GmbH unit. Mersana Therapeutics Inc., Cambridge, Mass. ...
http://www.biocentury.com/bcapp/BioCenturyCommon/CustomerSer...
|
Search Results | Takeda Pharmaceutical Company Limited
Cephalon and Takeda Announce Agreement to Co-Promote PROVIGIL® in the United States ... constipation," said Art Rice, general manager, Gastroenterology. ...
http://www.takeda.com/search/?q=companie...
|
